表紙
市場調査レポート

神経刺激装置:世界のパイプライン分析・競合展望および2018年までの市場予測

Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

発行 GlobalData 商品コード 201130
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
神経刺激装置:世界のパイプライン分析・競合展望および2018年までの市場予測 Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
出版日: 2012年06月30日 ページ情報: 英文 99 Pages
概要

全世界の神経刺激装置の市場規模は、2011年には23億米ドル、2018年には44億米ドルに達する(2011〜2018年の年平均成長率は10%)、と予測されています。慢性痛・パーキンソン病・てんかんといった発症件数が増加している疾患での治療のため需要が、成長を促進させるものと思われます。

当レポートでは、神経刺激装置の世界市場について分析し、市場全体の構造や、総収益の実績値・予測値(2004〜2018年)、部門別・国別の詳細動向、主要企業のプロファイル、パイプライン製品、資本取引動向などの情報を盛り込んで、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 疾患の概要

  • 慢性痛
    • 神経刺激で治療できる慢性痛の種類
    • 疫学
    • 治療
  • パーキンソン病
    • 疫学
    • 治療
  • てんかん
    • 疫学
    • 治療

第4章 神経刺激装置への医療費還付

  • 脊髄刺激装置
  • 脳深部刺激装置
  • 仙骨神経刺激装置
  • 迷走神経刺激装置
  • 「人道的医療機器」(Humanitarian Use Devices)としての神経刺激装置への医療費還付
  • メディケア(Medicare)・メディケイド(Medicaid)サービスセンターの医療費支払い方式の変更
    • 通院外科診療所(Ambulatory Surgical Center)の利用料金率
    • メディケアの外来患者向け医療費(2011年)

第5章 神経刺激装置の概要

  • 市場の分類
    • 脊髄刺激装置
    • 脳深部刺激装置
    • 仙骨神経刺激装置
    • 迷走神経刺激装置
    • 皮質刺激装置市場

第6章 世界市場の特徴

  • 市場収益実績値(2004〜2011年)
  • 市場収益予測値(2011〜2018年)
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第7章 各国市場の分析:市場収益(2004〜2018年)

  • 市場収益の実績値・予測値:米国(2004〜2018年)
  • 市場収益の実績値・予測値:カナダ(2004〜2018年)
  • 市場収益の実績値・予測値:英国(2004〜2018年)
  • 市場収益の実績値・予測値:ドイツ(2004〜2018年)
  • 市場収益の実績値・予測値:フランス(2004〜2018年)
  • 市場収益の実績値・予測値:イタリア(2004〜2018年)
  • 市場収益の実績値・予測値:スペイン(2004〜2018年)
  • 市場収益の実績値・予測値:日本(2004〜2018年)
  • 市場収益の実績値・予測値:中国(2004〜2018年)
  • 市場収益の実績値・予測値:インド(2004〜2018年)
  • 市場収益の実績値・予測値:オーストラリア(2004〜2018年)
  • 市場収益の実績値・予測値:ブラジル(2004〜2018年)

第8章 戦略的競合企業評価

  • 企業シェア(全世界、2011年)
  • Medtronic
  • St Jude Medical
  • Boston Scientific
  • Cyberonics

第9章 パイプライン評価

  • 脊髄刺激装置のパイプライン製品(全7件)
  • 脳深部刺激装置のパイプライン製品(全11件)
  • 仙骨神経刺激装置のパイプライン製品(全3件)
  • 迷走神経刺激装置のパイプライン製品(全4件)
  • 皮質刺激装置市場のパイプライン製品(全1件:Cortistim)
  • その他のパイプライン上の神経刺激装置

第10章 取引分析

  • 企業合併・買収(全4件)
  • ベンチャーキャピタル取引(全11件)
  • パートナーシップ取引(全3件)

第11章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDME0155MAR

Summary

GlobalData's new report, "Neurostimulation Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global neurostimulation devices market. It outlines the market landscape and provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
  • Key segments covered are spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators and cortical stimulators.
  • Annualized market revenues data from 2004 to 2011, forecast to 2018, and company share data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints by category within the neurostimulation devices market.
  • Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
  • Key players covered include Medtronic, St. Jude Medical, Boston Scientific Corporation and Cyberonics.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the neurostimulation devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • What is the next big thing in the neurostimulation devices market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global neurostimulation devices market and the factors shaping it.

Table of contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Disease Overview

  • 3.1. Chronic Pain
    • 3.1.1. Types of Chronic Pain Treated with Neurostimulation
    • 3.1.2. Epidemiology
    • 3.1.3. Treatment
  • 3.2. Parkinson's Disease
    • 3.2.1. Epidemiology
    • 3.2.2. Treatment
  • 3.3. Epilepsy
    • 3.3.1. Epidemiology
    • 3.3.2. Treatment

4. Reimbursement for Neurostimulation Devices

  • 4.1. Spinal Cord Stimulators
  • 4.2. Deep Brain Stimulators
  • 4.3. Sacral Nerve Stimulators
  • 4.4. Vagus Nerve Stimulators
  • 4.5. Reimbursement for Neurostimulators Developed as Humanitarian Use Devices
  • 4.6. Centers for Medicare and Medicaid Services Payment Changes, 2011
    • 4.6.1. Ambulatory Surgical Center Payment System Rates, 2011
    • 4.6.2. US Medicare Hospital Outpatient Payment Rates, 2011

5. Device Overview - Neurostimulation Devices

  • 5.1. Market Segmentation
    • 5.1.1. Spinal Cord Stimulators
    • 5.1.2. Deep Brain Stimulators
    • 5.1.3. Sacral Nerve Stimulators
    • 5.1.4. Vagus Nerve Stimulators
    • 5.1.5. Cortical Stimulators

6. Neurostimulation Devices Market - Global Market Characterization

  • 6.1. Neurostimulation Devices Market, Global, Revenue ($m), Historic, 2004-2011
  • 6.2. Neurostimulation Devices Market, Global, Revenue ($m), Forecast, 2011-2018
  • 6.3. Neurostimulation Devices, Market Dynamics
    • 6.3.1. Market Drivers
    • 6.3.2. Market Restraints

7. Neurostimulation Devices Market, Revenue ($m), by Country, 2004-2018

  • 7.1. Neurostimulation Devices Market, The US, Revenue ($m), Historic, 2004-2011
  • 7.2. Neurostimulation Devices Market, The US, Revenue ($m), Forecast, 2011-2018
  • 7.3. Neurostimulation Devices Market, Canada, Revenue ($m), Historic, 2004-2011
  • 7.4. Neurostimulation Devices Market, Canada, Revenue ($m), Forecast, 2011-2018
  • 7.5. Neurostimulation Devices Market, The UK, Revenue ($m), Historic, 2004-2011
  • 7.6. Neurostimulation Devices Market, The UK, Revenue ($m), Forecast, 2011-2018
  • 7.7. Neurostimulation Devices Market, Germany, Revenue ($m), Historic, 2004-2011
  • 7.8. Neurostimulation Devices Market, Germany, Revenue ($m), Forecast, 2011-2018
  • 7.9. Neurostimulation Devices Market, France, Revenue ($m), Historic, 2004-2011
  • 7.10. Neurostimulation Devices Market, France, Revenue ($m), Forecast, 2011-2018
  • 7.11. Neurostimulation Devices Market, Italy, Revenue ($m), Historic, 2004-2011
  • 7.12. Neurostimulation Devices Market, Italy, Revenue ($m), Forecast, 2011-2018
  • 7.13. Neurostimulation Devices Market, Spain, Revenue ($m), Historic, 2004-2011
  • 7.14. Neurostimulation Devices Market, Spain, Revenue ($m), Forecast, 2011-2018
  • 7.15. Neurostimulation Devices Market, Japan, Revenue ($m), Historic, 2004-2011
  • 7.16. Neurostimulation Devices Market, Japan, Revenue ($m), Forecast, 2011-2018
  • 7.17. Neurostimulation Devices Market, China, Revenue ($m), Historic, 2004-2011
  • 7.18. Neurostimulation Devices Market, China, Revenue ($m), Forecast, 2011-2018
  • 7.19. Neurostimulation Devices Market, India, Revenue ($m), Historic, 2004-2011
  • 7.20. Neurostimulation Devices Market, India, Revenue ($m), Forecast, 2011-2018
  • 7.21. Neurostimulation Devices Market, Australia, Revenue ($m), Historic, 2004-2011
  • 7.22. Neurostimulation Devices Market, Australia, Revenue ($m), Forecast, 2011-2018
  • 7.23. Neurostimulation Devices Market, Brazil, Revenue ($m), Historic, 2004-2011
  • 7.24. Neurostimulation Devices Market, Brazil, Revenue ($m), Forecast, 2011-2018

8. Global Neurostimulation Devices Market - Strategic Competitive Assessment

  • 8.1. Neurostimulation Devices Market, Global, Company Share (%), 2011
  • 8.2. Medtronic
    • 8.2.1. Overview
    • 8.2.2. Medtronic, Key Marketed Products
  • 8.3. St Jude Medical
    • 8.3.1. Overview
    • 8.3.2. St Jude Medical, Marketed Products
  • 8.4. Boston Scientific
    • 8.4.1. Overview
    • 8.4.2. Boston Scientific, Marketed Products
  • 8.5. Cyberonics
    • 8.5.1. Overview
    • 8.5.2. Cyberonics, Key Marketed Products

9. Neurostimulation Devices Market - Pipeline Assessment

  • 9.1. Spinal Cord Stimulators, Pipeline Products
    • 9.1.1. Algostim Device
    • 9.1.2. Genesis Neurostimulation System
    • 9.1.3. Nevro Senza System
    • 9.1.4. Next Generation Spinal Cord Stimulator System
    • 9.1.5. Precision Plus Spinal Cord Stimulation System
    • 9.1.6. PrimeADVANCED - Heart Failure
    • 9.1.7. Subcutaneous Array of Implantable Neural Transponder System
  • 9.2. Deep Brain Stimulators, Pipeline Products
    • 9.2.1. Activa PC - Refractory Epilepsy
    • 9.2.2. Brio Neurostimulator
    • 9.2.3. Coordinated Reset-Capable Implant
    • 9.2.4. Deep Brain Stimulation - Alzheimer's Disease
    • 9.2.5. Deep Brain Stimulation - Mild Cognitive Impairment
    • 9.2.6. Deep Brain Stimulation System - Cachexia
    • 9.2.7. Deep Brain Stimulation System - Obesity
    • 9.2.8. Deep Brain Stimulation System - Post-Traumatic Stress Disorder
    • 9.2.9. Deep Transcranial Magnetic Stimulation System - Alzheimer's Disease
    • 9.2.10. Deep Transcranial Magnetic Stimulation System - Autism
    • 9.2.11. Deep Transcranial Magnetic Stimulation System - Bipolar Disorder
  • 9.3. Sacral Nerve Stimulators, Pipeline Products
    • 9.3.1. Sacral Nerve Stimulation Device
    • 9.3.2. SAINT System - Urinary Incontinence
    • 9.3.3. Verv System - Overactive Bladder
  • 9.4. Vagus Nerve Stimulators, Pipeline Products
    • 9.4.1. Aspire New Parameters
    • 9.4.2. CardioFit System
    • 9.4.3. FitNes System - Alzheimer's Disease
    • 9.4.4. NEMOS - Epilepsy
  • 9.5. Cortical Stimulators, Pipeline Products
    • 9.5.1. Cortistim
  • 9.6. Other Neurostimulation Devices in the Pipeline

10. Neurostimulation Devices Market - Deals Landscape

  • 10.1. Neurostimulation Devices Market: Mergers and Acquisitions
    • 10.1.1. Sorin Group Invests $7m in Enopace Biomedical
    • 10.1.2. Otto Bock Healthcare Acquires Remaining 44.4% Joint Venture Stake in Neurostream Technologies from Victhom Human Bionics
    • 10.1.3. Boston Scientific Sells Neurovascular Business Unit to Stryker
    • 10.1.4. Vycor Medical Completes Acquisition of NovaVision
  • 10.2. Global Neurostimulation Devices Market, Venture Capital Deals
    • 10.2.1. Functional Neuromodulation Raises Additional $3m in Venture Financing
    • 10.2.2. Nervomatrix Secures $3.5m in Series A Venture Financing
    • 10.2.3. Cortec Secures $3.2m in Seed Financing
    • 10.2.4. ImThera Medical Secures $4m in Series C Venture Financing
    • 10.2.5. Phagenesis Secures $9.3m in Series B Venture Financing
    • 10.2.6. Autonomic Technologies Secures $32m in Series C Venture Financing
    • 10.2.7. SPR Therapeutics Secures $0.25m in Financing Round
    • 10.2.8. Nexstim Secures Additional $2.8m in Venture Financing Round
    • 10.2.9. BlueWind Medical Secures Seed Financing
    • 10.2.10. Synapse Biomedical Secures $0.43m in Financing Round
    • 10.2.11. EBS Technologies Secures $4.4m in Second Round of Financing
  • 10.3. Global Neurostimulation Devices Market, Partnership Deals
    • 10.3.1. GE Healthcare Enters into a Distribution Agreement with KC BioMedix
    • 10.3.2. EndoStim Enters into an Agreement with Arizona State University
    • 10.3.3. Ardiem Medical Enters into Licensing Agreement with Case Western Reserve University

11. Appendix

  • 11.1. Definitions
    • 11.1.1. Neurostimulation Devices
  • 11.2. Acronyms
  • 11.3. Sources
  • 11.4. Research Methodology
    • 11.4.1. Secondary Research
    • 11.4.2. Primary Research
    • 11.4.3. Models
    • 11.4.4. Forecasts
    • 11.4.5. Expert Panels
  • 11.5. GlobalData Consulting
  • 11.6. Contact Us
  • 11.7. Disclaimer

List of Tables

  • Table 1: Ambulatory Surgical Center Medicare Payment for Spinal Cord Stimulation, 2010 vs. 2011
  • Table 2: Ambulatory Surgical Center Medicare Payment for Deep Brain Stimulation, 2010 vs. 2011
  • Table 3: Ambulatory Surgical Center Medicare Payment for Sacral Nerve Stimulation, 2010 vs. 2011
  • Table 4: Medicare Hospital Outpatient Payment for Spinal Cord Stimulation, 2010 vs. 2011
  • Table 5: Medicare Hospital Outpatient Payment for Sacral Nerve Stimulation, 2010 vs. 2011
  • Table 6: Medicare Hospital Outpatient Payment for Deep Brain Stimulation, 2010 vs. 2011
  • Table 7: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011
  • Table 8: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018
  • Table 9: Healthcare Costs vs. Health-related Quality of Life with Spinal Cord Stimulation and Conventional Medical Management
  • Table 10: Incremental Cost-effectiveness of Spinal Cord Stimulation Compared with Conventional Medical Management
  • Table 11: Cost Effectiveness, Post-vagus Nerve Stimulation Therapy vs. Pre-vagus Nerve Stimulation Therapy
  • Table 12: Example of Neurostimulation Products* through FDA's Fast-track Program
  • Table 13: Example of Neurostimulation Products* through FDA's Humanitarian Device Exemption Program
  • Table 14: Pipeline Products In Development for New Indications
  • Table 15: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011
  • Table 16: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018
  • Table 17: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011
  • Table 18: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018
  • Table 19: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011
  • Table 20: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018
  • Table 21: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011
  • Table 22: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018
  • Table 23: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011
  • Table 24: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018
  • Table 25: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011
  • Table 26: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018
  • Table 27: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011
  • Table 28: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018
  • Table 29: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011
  • Table 30: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018
  • Table 31: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011
  • Table 32: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018
  • Table 33: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011
  • Table 34: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018
  • Table 35: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011
  • Table 36: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018
  • Table 37: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011
  • Table 38: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018
  • Table 39: Neurostimulation Devices Market, Global, Company Revenue ($m), 2011
  • Table 40: Medtronic, Key Marketed Products*, Neurostimulation Devices
  • Table 41: Activa RC, PC and SC Series Neurostimulator, Features and Benefits
  • Table 42: Kinetra Neurostimulator, Features and Benefits
  • Table 43: Soletra Neurostimulator, Features and Benefits
  • Table 44: Restore Series Neurostimulator, Features and Benefits
  • Table 45: PrimeAdvanced Neurostimulator, Features and Benefits
  • Table 46: Itrel 3 neurostimulator, Features and Benefits
  • Table 47: External Trialing System, Features and Benefits
  • Table 48: St Jude Medical, Key Marketed Products*, Neurostimulation Devices
  • Table 49: Libra Family of Primary Cell IPGs, Features and Benefits
  • Table 50: Eon C Primary Cell IPGs, Features and Benefits
  • Table 51: Genesis Primary Cell IPG, Features and Benefits
  • Table 52: Rechargeable IPGs, Features and Benefits
  • Table 53: Boston Scientific, Key Marketed Products*, Neurostimulation Devices
  • Table 54: Precision Plus Spinal Cord Stimulation System, Features and Benefits
  • Table 55: Cyberonics, Key Marketed Products*, Neurostimulation Devices
  • Table 56: VNS Therapy Generator, Features and Benefits
  • Table 57: Spinal Cord Stimulators, Pipeline Products
  • Table 58: Algostim Device, Product Status
  • Table 59: Genesis Neurostimulation System - Chronic Angina, Product Status
  • Table 60: Nevro Senza System, Product Status
  • Table 61: Next Generation Spinal Cord Stimulator System, Product Status
  • Table 62: Precision Plus Spinal Cord Stimulation System, Product Status
  • Table 63: PrimeAdvanced - Heart Failure, Product Status
  • Table 64: Subcutaneous Array of Implantable Neural Transponder System - Chronic Pain, Product Status
  • Table 65: Deep Brain Stimulators, Pipeline Products
  • Table 66: Activa PC - Refractory Epilepsy, Product Status
  • Table 67: Brio Neurostimulator, Product Status
  • Table 68: CR-Capable Implant, Product Status
  • Table 69: Deep Brain Stimulation - Alzheimer's Disease, Product Status
  • Table 70: Deep Brain Stimulation - Mild Cognitive Impairment, Product Status
  • Table 71: Deep Brain Stimulation - Cachexia, Product Status
  • Table 72: Deep Brain Stimulation - Obesity, Product Status
  • Table 73: Deep Brain Stimulation - Post-Traumatic Stress Disorder
  • Table 74: Deep TMS System - Alzheimer's Disease, Product Status
  • Table 75: Deep Transcranial Magnetic Stimulation System - Autism, Product Status
  • Table 76: Deep Transcranial Magnetic Stimulation System - Bipolar Disorder, Product Status
  • Table 77: Sacral Nerve Stimulators, Pipeline Products
  • Table 78: Sacral Nerve Stimulation Device, Product Status
  • Table 79: SAINT System - Urinary Incontinence, Product Status
  • Table 80: Verv System - Overactive Bladder, Product Status
  • Table 81: Vagus Nerve Stimulators, Pipeline Products
  • Table 82: Aspire NP, Product Status
  • Table 83: CardioFit System, Product Status
  • Table 84: FitNes System - Alzheimer's Disease, Product Status
  • Table 85: NEMOS - Epilepsy, Product Status
  • Table 86: Cortical Stimulators, Pipeline Products
  • Table 87: Cortistim, Product Status
  • Table 88: Other Neurostimulation Devices in the Pipeline
  • Table 89: Neurostimulation Devices Market, Mergers and Acquisitions, Global, 2010-2011
  • Table 90: Global Neurostimulation Devices Market, Venture Capital Deals
  • Table 91: Global Neurostimulation Devices Market, Partnership Deals

List of Figures

  • Figure 1: Neurostimulation Devices, Market Segmentation
  • Figure 2: Neurostimulation Devices Market, Global, Revenue ($m), 2004-2011
  • Figure 3: Neurostimulation Devices Market, Global, Revenue ($m), 2011-2018
  • Figure 4: Neurostimulation Devices, Regulatory Path for Pipeline Products, 2012
  • Figure 5: Neurostimulation Devices Market, The US, Revenue ($m), 2004-2011
  • Figure 6: Neurostimulation Devices Market, The US, Revenue ($m), 2011-2018
  • Figure 7: Neurostimulation Devices Market, Canada, Revenue ($m), 2004-2011
  • Figure 8: Neurostimulation Devices Market, Canada, Revenue ($m), 2011-2018
  • Figure 9: Neurostimulation Devices Market, The UK, Revenue ($m), 2004-2011
  • Figure 10: Neurostimulation Devices Market, The UK, Revenue ($m), 2011-2018
  • Figure 11: Neurostimulation Devices Market, Germany, Revenue ($m), 2004-2011
  • Figure 12: Neurostimulation Devices Market, Germany, Revenue ($m), 2011-2018
  • Figure 13: Neurostimulation Devices Market, France, Revenue ($m), 2004-2011
  • Figure 14: Neurostimulation Devices Market, France, Revenue ($m), 2011-2018
  • Figure 15: Neurostimulation Devices Market, Italy, Revenue ($m), 2004-2011
  • Figure 16: Neurostimulation Devices Market, Italy, Revenue ($m), 2011-2018
  • Figure 17: Neurostimulation Devices Market, Spain, Revenue ($m), 2004-2011
  • Figure 18: Neurostimulation Devices Market, Spain, Revenue ($m), 2011-2018
  • Figure 19: Neurostimulation Devices Market, Japan, Revenue ($m), 2004-2011
  • Figure 20: Neurostimulation Devices Market, Japan, Revenue ($m), 2011-2018
  • Figure 21: Neurostimulation Devices Market, China, Revenue ($m), 2004-2011
  • Figure 22: Neurostimulation Devices Market, China, Revenue ($m), 2011-2018
  • Figure 23: Neurostimulation Devices Market, India, Revenue ($m), 2004-2011
  • Figure 24: Neurostimulation Devices Market, India, Revenue ($m), 2011-2018
  • Figure 25: Neurostimulation Devices Market, Australia, Revenue ($m), 2004-2011
  • Figure 26: Neurostimulation Devices Market, Australia, Revenue ($m), 2011-2018
  • Figure 27: Neurostimulation Devices Market, Brazil, Revenue ($m), 2004-2011
  • Figure 28: Neurostimulation Devices Market, Brazil, Revenue ($m), 2011-2018
  • Figure 29: Neurostimulation Devices Market, Global, Company Share* (%), 2011
  • Figure 30: Global Neurostimulation Devices, Product Mapping
  • Figure 31: Neurostimulation Devices, Analysis of Pipeline Products by Clinical Stage of Development
Back to Top